|Title:||Metered dose inhaler for fluticasone propionate|
|Abstract:||A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally a blend of one or more fluorocarbon polymers in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising fluticasone propionate or a physiologically acceptable solvate thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.|
|Inventor(s):||Britto; Ignatius Loy (Cary, NC)|
|Assignee:||Glaxo Wellcome Inc. (Research Triangle Park, NC) Glaxo Group Limited (Greenford, GB)|
Patent Claim Types:|
see list of patent claims
|Formulation; Delivery; Device; Use; Composition;|
Field: Medical technology
Back Citations: 109th percentile
Forward Citations: 2nd percentile
|Patent Number||Expiration Date|
|6,253,762||July 03, 2013|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||960||► subscribe|
|African Regional IP Organization (ARIPO)||9701111||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.